PAW Volume 3, Issue 1
3 REMS: Risk Management Strategies, Current Issues, and the Pharmacist's Role
Kristen Thatcher; Megan Stojic, PharmD
7 The Emerging Role of Ticagrelor in Acute Coronary Syndromes CE Included
Jennifer Bauer; Brittany Dye; Kimberly Baucher; Megan Keller, PharmD; David Bright, PharmD, BCACP; Karen L. Kier, BSPh, Ph.D., BCPS, BCACP
14 Fidazomicin (Dificid): New Antibiotic Approved for the Treatment of Clostridium difficile Infections CE Included
Sara N. McAllister; Zachary Crawford; Joshua Ilenin; Ellen Hazelet; Andrew Roecker, PharmD, BCPS
20 An Update on Acetaminophen Labeling Changes: A Pharmacist's Call to Action
Rebecca Airel; Kayla Durkin; Taylor Gauthier; Jamie Amero; Natalie A. DiPietro, PharmD, MPH
23 Safety and Efficacy of Human Chorionic Gonadotropin (hCG) in Weight Loss
Todd A. Tucker Jr.; Justin W. Steele; Amanda Hoersten; Amanda Meyer; Sandra L. Hrometz, BSPh, Ph.D., R.Ph
26 Lithium Therapy in Alzheimer's Disease
Ross Robison; Sara Swick; Lauren Bajbus; Jennifer Bauer; B. Shane Martin, PharmD
29 The Use of Crizotinib in Late Stage Lung Cancer Patients with an Abnormal ALK Gene
Lara Long; Kelly Dye; Courtney Porter; Ellen Hazelet; Karen L. Kier, BSPh, Ph.D., BCPS, BCACP
32 Effects of Hormone Therapy on Cognition in Post-menopausal Women
Jessical Langhals; Megan Meyer; Erica Schoenberger; Amanda Meyer; Kristen Finley Sobota, PharmD, BCPS
35 Pharmacogenetic Implications Regarding Second Generation Antipsychotics Clozapine and Risperidone
Sarah E. Ginty; Amy Pasternak; Lauren Desko; Jamie Amero; David Kisor, BS, PharmD
Kristen Thatcher; Megan Stojic, PharmD
7 The Emerging Role of Ticagrelor in Acute Coronary Syndromes CE Included
Jennifer Bauer; Brittany Dye; Kimberly Baucher; Megan Keller, PharmD; David Bright, PharmD, BCACP; Karen L. Kier, BSPh, Ph.D., BCPS, BCACP
14 Fidazomicin (Dificid): New Antibiotic Approved for the Treatment of Clostridium difficile Infections CE Included
Sara N. McAllister; Zachary Crawford; Joshua Ilenin; Ellen Hazelet; Andrew Roecker, PharmD, BCPS
20 An Update on Acetaminophen Labeling Changes: A Pharmacist's Call to Action
Rebecca Airel; Kayla Durkin; Taylor Gauthier; Jamie Amero; Natalie A. DiPietro, PharmD, MPH
23 Safety and Efficacy of Human Chorionic Gonadotropin (hCG) in Weight Loss
Todd A. Tucker Jr.; Justin W. Steele; Amanda Hoersten; Amanda Meyer; Sandra L. Hrometz, BSPh, Ph.D., R.Ph
26 Lithium Therapy in Alzheimer's Disease
Ross Robison; Sara Swick; Lauren Bajbus; Jennifer Bauer; B. Shane Martin, PharmD
29 The Use of Crizotinib in Late Stage Lung Cancer Patients with an Abnormal ALK Gene
Lara Long; Kelly Dye; Courtney Porter; Ellen Hazelet; Karen L. Kier, BSPh, Ph.D., BCPS, BCACP
32 Effects of Hormone Therapy on Cognition in Post-menopausal Women
Jessical Langhals; Megan Meyer; Erica Schoenberger; Amanda Meyer; Kristen Finley Sobota, PharmD, BCPS
35 Pharmacogenetic Implications Regarding Second Generation Antipsychotics Clozapine and Risperidone
Sarah E. Ginty; Amy Pasternak; Lauren Desko; Jamie Amero; David Kisor, BS, PharmD
pharmacy_and_wellness_review_january_2012.pdf | |
File Size: | 2323 kb |
File Type: |
PAW Volume 3, Issue 2
40 Impact of Community Pharmacists on Management of Cancer Chemotherapy and the Resulting Side Effects CE Included
Jacquline M. Nunner; Jessica Stemen; Courtney Porter; Ellen Hazelet; Mark Olah, R.Ph., Ph.D.
48 Lysteda for Heavy Menstrual Bleeding CE Included
Erica B. Schoenberger; Todd A. Tucker Jr.; Justin W. Steele; Amanda Meyer; Sandra L. Hrometz, BSPh, R.Ph., Ph.D.
54 Laboratory Mutations of H5N1 Confer Efficient Transmission in Animal Models and Generate International Debate Regarding Publication of Dual Use Research
Morgan A. Belling; Kelly Dye; Joshua Ilenin; Jamie Amero; Andrew Roecker, PharmD, BCPS
58 Dronedarone: An Update to a Controversial Therapy for Atrial Fibrillation
Zachary Crawford; Sara McAllister; Amanda Hoersten; Jennifer Bauer; Megan Keller, PharmD; David Bright, PharmD, BCACP
63 Improving Maternal and Fetal Health: A Look at Thyroid Function During Pregnancy
Sarah Ginty; Jessica Beck; Taylor Gauthier; Amanda Meyer; Michelle Musser, PharmD
66 Emerging Therapies for the Treatment of Multiple Sclerosis
Sara Swick; Amy Gillman; Lauren Bajbus; Jennifer Bauer; Jeffery Talbot, Ph.D.
70 The Impact of Pharmacogenomics on Chemotherapeutic Drug Development and Use
Lara Long; Amy Pasternak; Ellen Hazelet; David Kisor, BS, PharmD
74 E-Prescribing: Benefits and Challenges in Enhancing Patient Safety
Kayla Durkin; Rebecca Airel; Lauren Desko; Jamie Amero; Natalie DiPietro, PharmD, MPH
Jacquline M. Nunner; Jessica Stemen; Courtney Porter; Ellen Hazelet; Mark Olah, R.Ph., Ph.D.
48 Lysteda for Heavy Menstrual Bleeding CE Included
Erica B. Schoenberger; Todd A. Tucker Jr.; Justin W. Steele; Amanda Meyer; Sandra L. Hrometz, BSPh, R.Ph., Ph.D.
54 Laboratory Mutations of H5N1 Confer Efficient Transmission in Animal Models and Generate International Debate Regarding Publication of Dual Use Research
Morgan A. Belling; Kelly Dye; Joshua Ilenin; Jamie Amero; Andrew Roecker, PharmD, BCPS
58 Dronedarone: An Update to a Controversial Therapy for Atrial Fibrillation
Zachary Crawford; Sara McAllister; Amanda Hoersten; Jennifer Bauer; Megan Keller, PharmD; David Bright, PharmD, BCACP
63 Improving Maternal and Fetal Health: A Look at Thyroid Function During Pregnancy
Sarah Ginty; Jessica Beck; Taylor Gauthier; Amanda Meyer; Michelle Musser, PharmD
66 Emerging Therapies for the Treatment of Multiple Sclerosis
Sara Swick; Amy Gillman; Lauren Bajbus; Jennifer Bauer; Jeffery Talbot, Ph.D.
70 The Impact of Pharmacogenomics on Chemotherapeutic Drug Development and Use
Lara Long; Amy Pasternak; Ellen Hazelet; David Kisor, BS, PharmD
74 E-Prescribing: Benefits and Challenges in Enhancing Patient Safety
Kayla Durkin; Rebecca Airel; Lauren Desko; Jamie Amero; Natalie DiPietro, PharmD, MPH
pharmacy_and_wellness_review_july_2012.pdf | |
File Size: | 2400 kb |
File Type: |